Can probiotics change fish behavior?


Frank and her colleagues in Christina Semeniuk’s lab and comentor Daniel Heath’s lab at the University of Windsor in Ontario are trying to determine whether an unlikely intervention — a probiotic supplement in fish food — might help triploid Chinook salmon fare better. They’re starting with how the fish behave.
“Behavioral flexibility and sensitivity … would be an immediate measure for physiological (and neural genomic) change, given the connections between the gut–brain–behavior axis,” Semeniuk said.
Frank tested how probiotic supplements added to fish food affected the way hundreds of fingerling diploid and triploid fish respond to novel stimuli such as a glass bead tossed into the tank, a predator-shaped dummy passing overhead and an approaching human researcher. She will present her work as part of the Genomics poster session during the 2021 ASBMB annual meeting; you can see her talk and post questions while the meeting is underway.
In the future, Frank plans to integrate transcriptomic analyses with her behavioral studies, an approach known as behavioral genomics. Little is known about how triploidy affects genes related to learning and memory, so even if probiotics have little effect, she stands to learn something interesting.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.